Vascular endothelial growth factor and the eye: Biochemical mechanisms of action and implications for novel therapies

Ophthalmic Research

Volumn 29, Issue 5, 1997, Pages 354-362

  Aiello, Lloyd Paul ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

Adenosine; Diabetic retinopathy; Growth factors; Ischemic retinopathies; Permeability; Protein kinase C; Signal transduction; Tyrosine kinase; Vascular endothelial growth factor; Vasopermeability factor

Indexed keywords

ADENOSINE; GROWTH FACTOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; VASCULOTROPIN;

ANGIOGENESIS; BIOCHEMISTRY; CONFERENCE PAPER; DEVELOPED COUNTRY; DIABETIC RETINOPATHY; EYE; EYE DISEASE; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PERMEABILITY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETROLENTAL FIBROPLASIA; SIGNAL TRANSDUCTION; VISUAL IMPAIRMENT;

EID: 0030758411     PISSN: 00303747     EISSN: 14230259     Source Type: Journal    
DOI: 10.1159/000268033     Document Type: Article

References (50)

1. Klein HA, Moorehead HB: Statistics on Blindness in the Model Reporting Area, 1969-1970, DHEW Publ No NIH 73-427, 1970, Bethes-da, US Department of Health, Education and Welfare, 1973.
2. Klein R, Klein BEK: Vision disorders in diabetes; in National Diabetes Data Group: Diabetes in America: Diabetes Data Compiled 1984, NIH Publ No 85-1468, Be-thesda, US Department of Health and Human Services, 1985, pp 1-2.
3. Path A: Studies on retinal neovascularization, Invest Ophthalmol Vis Sci 1980:19:1133-1138.
4. Aiello L, Wand M, Liang G: Neo-vascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes melli-tus, Ophthalmology 1983:90:814-820.
5. Michaelson IC: The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal disease, Trans Ophthalmol Soc UK 1948;68:137-180.
6. Gartner S, Henkind P: Neovascularization of the iris (rubeosis iridis), Surv Ophthalmol 1978;22:291-312.
7. Henkind P: Ocular neovascularization, Am J Ophthalmol 1978,85: 287-301.
8. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion, Arch Ophthalmol 1986; 104:34-41.
9. Early Treatment Diabetic Retinopathy Study Report Number 9: Early photocoagulation for diabetic retinopathy, Ophthalmology 1991:98:766-785.
10. Ashton N: Retinal vascularization in health and disease, Am J Ophthalmol 1957;44:7-24.
11. Montesano R, Vassali JD, Baird A, Guillcmin R, Orci L: Basic fibroblast growth factor induces angiogenesis in vitro, Proc Natl Acad Sci USA 1986:83:7297-7301.
12. Shing Y, Folkman J, Haudenschild C, Lund D, Crum R, Klagsbrun M: Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor, J Cell Biochem 1985:29:275-287.
13. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowiez D, Fiddcs JC: Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor, Science 1986:233:545-548.
14. LeRoith D, Roberts CT Jr.: Insulinlike growth factors, Ann NY Acad Sci 1993:692:1-9.
15. Grant MB, Mantes RN, Fitgerald C, Ellis EA, Caballero S, Chcgini N, Guv J: Insulin-like growth factor I as an angiogenic agent: In vivo and in vitro studies, Ann NY Acad Sci 1993;692:230-242.
16. Scngcr DR, Galli SJ, Dvorak AM, Pcrruzzi CA, Hanev VS, Dvorak JF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid, Science 1983:219:983-985.
17. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT: Vascular permeability factor, an endothelial cell mitogen related to PDGF, Science 1989:246:1309-1312.
18. Leung DW, Cachianes G, Kunang WJ, Goeddcl DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen, Science 1989;246:1306-1309.
19. Ferrara N, Houck KA, Jakcntan LB, Winer J, Leung DW: The vascular endothelial growth factor family of polypeptides, J Cell Biochcnt 1991: 47:211-218.
20. Senger D, Connolly D, Van De Water L, Feder J, Dvorak H: Purification and NH2-terminal amino acid sequence of guinea pig tuinor-sc-creted vascular permeability factor, Cancer Res 1990:50:1774-1778.
21. Pepper M, Ferrara N, Orci L, Mon-lesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro, Biochem Biophys Res Commun 1992;189:824-831.
22. Adamis AP, Shima DT, Yeo K-T, Yeo T-K, Brown LF, Bcrsc B, D'Amorc PA, Folkman J: Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells, Biochem Bio-phys Res Commun 1993:193:631-638.
23. Aiello L, Northrup J, Keyt B, Keyi B, Takagi H, Iwamoto M: Hypoxic regulation of vascular endothelial growth factor in retinal cells, Arch Ophthalmol 1995:113:1538-1544.
24. Yang Q, Zwijsen A, Sieger H, Van-den Berghe D: Purification and characterization of VEGF/VPF secreted by human retinal pigment epithelial cells, Endothelium 1994: 2:73-85.
25. Simorre P, Guerrin M, Chollet P, Penary M, Clamens S, Malecaze F, Plouet J: Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway, Invest Ophthalmol Vis Sci 1994:35:3393-3400.
26. Nomura M, Yamagishi S, Harada S, Havashi Y, Yamashima T, Yanta-shita J, Yamamoto H: Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes, J Biol Client 1995:270: 28316-28324.
27. Shima DT, Adamis AP, Ferrara N, Yeo KT, Yeo TK, Allende R, Folkman J, D'Amorc PA: Hypoxic induction of endothelial cell growth factors in retinal cells: Identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen, Mol Med 1995:1:182-193.
28. Thicme H, Aiello LP, Takagi H, Ferrara N, King GL: Comparative analysis of vascular endothelial growth factor (VEGF) receptors on retinal and aortic microvascular endothelial cells, Diabetes 1994:44: 98-103.
29. Smith L, Wesolowski E, McLellan A, Kostyk S, D'amato R, Sullivan R: Oxygen-induced retinopathy in the mouse, Invest Ophthalmol Vis Sci 1994:35:101-111.
30. Stone J, Chang-Ling T, Pe're J, ltin A, Gnessin H, Kcshet E: Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity, Invest Ophthalmol Vis Sci 1966: 37:290-299.
31. Miller JW, Adamis AP, Shima D, D'amore PA, Moulton R, O'Reilly M, Folkman J, Brown L, Berse B, Yeo T-K, Yeo K-T: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular an-giogcncsis in a primate model, am J Pathol 1994:145:574-584.
32. Aiello LP, Avery RL, Arrigg PG, Kcvt B, Aiello LM, Jampel HD, Shah ST, Pasquale LR, Thiente H, hvamoto MA, Park JE, Nguyen HV, Ferrara N, King GL: Vascular endothelial growth factor in ocular tluids of patients with diabetic retinopathy and other retinal disorders, N F.ngl J Med 1994:331:1480-1487.
33. Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo T-K, Yeo K-T: Elevated vascular permeability factor/vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy, Am J Ophthalmol 1994:118:445-450.
34. Malecaze F, Clamens S, Simorre-Pinatel V, Chollct P, Favard C, Bayard F, Plouet J: Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy, Arch Ophthalmol 1994:112:1476-1482.
35. Lutty GA, McLeod GS, Merges C, Diggs A, Plouet J: Localization of vascular endothelial growth factor in human retina and choroid, Arch Ophthalmol 1996:114:971-977.
36. Vinores SA, Kuchlc M, Mahlow J, Chiu C, Green WR, Campochiaro PA: Blood-ocular barrier breakdown in eyes with ocular melanoma: A potential role for vascular endothelial growth factor/vascular permeability factor, Am J Pathol 1995:147:1289-1297.
37. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in the glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy, Invest Ophthalmol Vis Sci 1997:38:36-47.
38. Bontcmps F, Mimouni M, Van de Berghe G: Mechanisms of elevation of adenosine levels in anoxic hepato-cytes, J Biochem 1993:290:671-677.
39. Collis MG, Hourani SMO: Adenosine receptor subtype, Tips Rev 1993:14:360-366.
40. Hashimoto E, Kagc K, Ogita T, Na-kaoka T, Matsuoka R, Kira Y: Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells, Biochem Biophys Res Commun 1994:204:318-324.
41. Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP: Hypoxic induction of vascular endothelial growth factor (VEGF) is mediated by adenosine, adenosine A; receptors and cAMP-dcpendcnt protein kinase A in retinal microvascular pericytes and vascular endothelial cells, Invest Ophthalmol Vis Sci 1996:37:2165-2176.
42. Takagi H, King GL, Ferrara N, Aiello LP: Hypoxia regulates vascular endothelial growth factor receptor KDR/FIk gene expression through adenosine A; receptors in retinal capillary endothelial cells, Invest Ophthalmol Vis Sci 1996:37:1311-1321.
43. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH: Inhibition of vascular endothelial growth factor suppresses retinal neovascularization in vivo, Proc Nall Acad Sci 1995:92:10457-10461.
44. Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LEH: Oli-godcoxynuclcotidcs inhibit retinal neovascularization in a murine model of proliferative retinopathy, Proc Natl Acad Sci 1996:93:4851-4856.
45. Adamis A, Shima D, Tolentino M, Gragoudas E, Ferrara N, Folkman J, D'Amore P, Miller J: Inhibition of VEGF prevents ocular neovascularization in a non-human primate, Arch Ophthalmol 1996:114:66-71.
46. Guo D, Jia Q, Song HY, Warren RS, Donner DB: Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH: domains: Association with endothelial cell proliferation, J Biol Chem 1994:270:6729-6733.
47. Waltenbcrger J, Welsh I., Siegbahn A, Shibuva M, Heldin CH: Different signal transduction properties of KDR and Fit I, two receptors for vascular endothelial growth factor, J Biol Chem 1994:269:26988-26995.
48. Pu X, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, J irousck J, King GL: Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isofornts and endothelial cell growth, J Clin Invest 1996:98:2018-2026.
49. Duh E, Aiello LP, Takagi C, Clermont A, Mori F, King GL, Bursell SE: Vascular endothelial growth factor (VEGF) increases retinal vascular permeability in vivo, Ophthalmol Vis Sci 1996:37:S121.
50. Ishii H, Jirousck MR, Koya D, Takagi C, Xia P, Clermont A, Bursell SE, Kern TS, Balias LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKC ß inhibitor, Science 1996:272:728-731.